Different modalities to manage rheumatoid arthritis: an A to Z story

References

• Bullock J, Rizvi SAA, Saleh AM et al. Rheumatoid arthritis: a brief overview of the treatment. Med. Princ. Pract. 27(6), 501–507 (2018).
   PubMed Web of Science ®Google Scholar
• Gaffo A, Saag KG, Curtis JR. Treatment of rheumatoid arthritis. Am. J. Health Syst. Pharm. 63(24), 2451–2465 (2006).
   PubMed Web of Science ®Google Scholar
• Kłodziński Ł, Wisłowska M. Comorbidities in rheumatic arthritis. Reumatologia 56(4), 228–233 (2018).
   PubMedGoogle Scholar
• Dedmon LE. The genetics of rheumatoid arthritis. Rheumatology 59(10), 2661–2670 (2020).
   PubMed Web of Science ®Google Scholar
• Frisell T, Holmqvist M, Källberg H, Klareskog L, Alfredsson L, Askling J. Familial risks and heritability of rheumatoid arthritis: role of rheumatoid factor/anti-citrullinated protein antibody status, number and type of affected relatives, sex and age. Arthritis Rheum. 65(11), 2773–2782 (2013).
   PubMed Web of Science ®Google Scholar
• Chauhan K, Jandu JS, Brent LH, Al-Dhahir MA. Rheumatoid Arthritis. [Updated 2022 Nov 21]. In: StatPearls [Internet]. StatPearls Publishing, FL, USA (2022). Available from: https://www.ncbi.nlm.nih.gov/books/NBK441999/
   Google Scholar
• Derksen VFAM, Huizinga TWJ, van der Woude D. The role of autoantibodies in the pathophysiology of rheumatoid arthritis. Semin. Immunopathol. 39(4), 437–446 (2017).
   PubMed Web of Science ®Google Scholar
• Bullock J, Rizvi SAA, Saleh AM et al. Rheumatoid arthritis: a brief overview of the treatment. Med. Princ. Pract. 27(6), 501–507 (2018).
   PubMed Web of Science ®Google Scholar
• Şen V, Ece A, Uluca Ü et al. Evaluation of children with juvenile idiopathic arthritis in southeastern Turkey: a single center experience. Hippokratia 19(1), 63–68 (2015).
   PubMed Web of Science ®Google Scholar
• Guo Q, Wang Y, Xu D, Nossent J, Pavlos NJ, Xu J. Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies. Bone Res. 6, 15 (2018).
   PubMed Web of Science ®Google Scholar
• Hejazi J, Mohtadinia J, Kolahi S, Bakhtiyari M, Delpisheh A. Nutritional status of Iranian women with rheumatoid arthritis: an assessment of dietary intake and disease activity. Wom. Health 7(5), 599–605 (2011).
   Google Scholar
• Turesson Wadell A, Bärebring L, Hulander E, Gjertsson I, Lindqvist HM, Winkvist A. Inadequate dietary nutrient intake in patients with rheumatoid arthritis in Southwestern Sweden: a cross-sectional study. Front. Nutr. 9, 915064 (2022).
   PubMed Web of Science ®Google Scholar
• Skiba MB, Hopkins LL, Hopkins AL, Billheimer D, Funk JL. Nonvitamin, nonmineral dietary supplement use in individuals with rheumatoid arthritis. J. Nutr. 150(9), 2451–2459 (2020).
   PubMed Web of Science ®Google Scholar
• Darlington LG, Stone TW. Antioxidants and fatty acids in the amelioration of rheumatoid arthritis and related disorders. Br. J. Nutr. 85, 251–269 (2001).
   PubMed Web of Science ®Google Scholar
• Radu AF, Bungau SG. Management of rheumatoid arthritis: an overview. Cells 10(11), 2857 (2021).
   PubMed Web of Science ®Google Scholar
• Staheli LT. Lower extremity management. In: Arthrogryposis: A Text Atlas. Hall JG, Jaffe KM, Paholke DO ( Eds). Cambridge University Press, Cambridge, UK, 55–73 (1998).
   Google Scholar
• Benjamin O, Goyal A, Lappin SL. Disease - Modifying Antirheumatic Drugs (DMARD) [Updated 2023 Jul 3]. In: StatPearls [Internet]. StatPearls Publishing, Treasure Island FL, UK (2023). Available from: https://www.ncbi.nlm.nih.gov/books/NBK507863/
   Google Scholar
• Elkayam O, Yaron I, Shirazi I, Judovitch R, Caspi D, Yaron M. Active leflunomide metabolite inhibits interleukin 1beta, tumour necrosis factor alpha, nitric oxide, and metalloproteinase-3 production in activated human synovial tissue cultures. Ann. Rheum. Dis. 62(5), 440–443 (2003).
   PubMed Web of Science ®Google Scholar
• Diaz-Ruiz A, Vergara P, Perez-Severiano F et al. Cyclosporin-A inhibits constitutive nitric oxide synthase activity and neuronal and endothelial nitric oxide synthase expressions after spinal cord injury in rats. Neurochem. Res. 30(2), 245–251 (2005).
   PubMed Web of Science ®Google Scholar
• Mittal N, Mittal R, Sharma A, Jose V, Wanchu A, Singh S. Treatment failure with disease-modifying antirheumatic drugs in rheumatoid arthritis patients. Singapore Med. J. 53(8), 532–536 (2012).
   PubMed Web of Science ®Google Scholar
• Fatani AZ, Bugshan NA, AlSayyad HM et al. Causes of the failure of biological therapy at a tertiary center: a cross-sectional retrospective study. Cureus 13(9), e18253 (2021).
   PubMed Web of Science ®Google Scholar
• Kim M, Choe YH, Lee SI. Lessons from the success and failure of targeted drugs for rheumatoid arthritis: perspectives for effective basic and translational research. Immune Netw. 22(1), e8 (2022).
   PubMed Web of Science ®Google Scholar
• Fleischmann R, Schiff M, van der Heijde D et al. Baricitinib, methotrexate, or combination in patients with rheumatoid arthritis and no or limited prior disease-modifying antirheumatic drug treatment. Arthr. Rheumatol. 69, 506–517 (2017).
   PubMed Web of Science ®Google Scholar
• He J, Wang Y, Feng M et al. Dietary intake and risk of rheumatoid arthritis – a cross section multicenter study. Clin. Rheum. 35, 2901–2908 (2016).
   PubMedGoogle Scholar
• Benito-Garcia E, Feskanich D, Hu FB, Mandl LA, Karlson EW. Protein, iron, and meat consumption and risk for rheumatoid arthritis: a prospective cohort study. Arthritis Res. Ther. 9, R16 (2007).
   PubMed Web of Science ®Google Scholar
• Kjeldsen-Kragh J, Mellbye O, Haugen M et al. Changes in laboratory variables in rheumatoid arthritis patients during a trial of fasting and one-year vegetarian diet. Scand. J. Rheumatol. 24(2), 85–93 (1995).
   PubMed Web of Science ®Google Scholar
• Podas T, Nightingale JM, Oldham R, Roy S, Sheehan NJ, Mayberry JF. Is rheumatoid arthritis a disease that starts in the intestine? A pilot study comparing an elemental diet with oral prednisolone. Postgrad. Med. J. 83(976), 128–131 (2007).
   PubMed Web of Science ®Google Scholar
• Alipour B, Homayouni-Rad A, Vaghef-Mehrabany E et al. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. Int. J. Rheum. Dis. 17(5), 519–527 (2014).
   PubMed Web of Science ®Google Scholar
• Zamani B, Golkar HR, Farshbaf S et al. Clinical and metabolic response to probiotic supplementation in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled trial. Int. J. Rheum. Dis. 19(9), 869–879 (2016).
   PubMed Web of Science ®Google Scholar
• Karatay S, Erdem T, Yildirim K et al. The effect of individualized diet challenges consisting of allergenic foods on TNF-α and IL-1β levels in patients with rheumatoid arthritis. Rheumatology 43(11), 1429–1433 (2004).
   PubMed Web of Science ®Google Scholar
• Mandel DR, Eichas K, Holmes J. Bacillus coagulans: a viable adjunct therapy for relieving symptoms of rheumatoid arthritis according to a randomized, controlled trial. BMC Complement Altern. Med. 10(1), 1 (2010).
   PubMedGoogle Scholar
• Vadell AKE, Bärebring L, Hulander E, Gjertsson I, Lindqvist HM, Winkvist A. Anti-inflammatory diet in rheumatoid arthritis (ADIRA)-a randomized, controlled crossover trial indicating effects on disease activity. Am. J. Clin. Nutr. 111(6), 1203–1213 (2020).
   PubMed Web of Science ®Google Scholar
• Thimóteo NSB, Iryioda TMV, Alfieri DF et al. Cranberry juice decreases disease activity in women with rheumatoid arthritis. Nutrition 60, 112–117 (2019).
   PubMed Web of Science ®Google Scholar
• Lindqvist HM, Gjertsson I, Eneljung T, Winkvist A. Influence of blue mussel (Mytilus edulis) intake on disease activity in female patients with rheumatoid arthritis: the MIRA randomized cross-over dietary intervention. Nutrients 10(4), 481 (2018).
   PubMed Web of Science ®Google Scholar
• Aryaeian N, Shahram F, Mahmoudi M et al. The effect of ginger supplementation on some immunity and inflammation intermediate genes expression in patients with active rheumatoid arthritis. Gene 698, 179–185 (2019).
   PubMed Web of Science ®Google Scholar
• Shishehbor F, Rezaeyan Safar M, Rajaei E, Haghighizadeh MH. Cinnamon consumption improves clinical symptoms and inflammatory markers in women with rheumatoid arthritis. J. Am. Coll. Nutr. 3, 1–6 (2018).
   Google Scholar
• Hamidi Z, Aryaeian N, Abolghasemi J et al. The effect of saffron supplement on clinical outcomes and metabolic profiles in patients with active rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Phytother. Res. 34(7), 1650–1658 (2020).
   PubMed Web of Science ®Google Scholar
• Sköldstam L, Hagfors L, Johansson G. An experimental study of a Mediterranean diet intervention for patients with rheumatoid arthritis. Ann. Rheum. Dis. 62(3), 208–214 (2003).
   PubMed Web of Science ®Google Scholar
• Mirtaheri E, Gargari BP, Kolahi S et al. Effects of alpha-lipoic acid supplementation on inflammatory biomarkers and matrix metalloproteinase-3 in rheumatoid arthritis patients. J. Am. Coll. Nutr. 34(4), 310–317 (2015).
   PubMed Web of Science ®Google Scholar
• Dawczynski C, Dittrich M, Neumann T et al. Docosahexaenoic acid in the treatment of rheumatoid arthritis: a double-blind, placebo-controlled, randomized cross-over study with microalgae vs. sunflower oil. Clin. Nutr. 37(2), 494–504 (2018).
   PubMed Web of Science ®Google Scholar
• Buondonno I, Rovera G, Sassi F et al. Vitamin D and immunomodulation in early rheumatoid arthritis: a randomized double-blind placebo-controlled study. PLOS ONE 12(6), e0178463 (2017).
   PubMed Web of Science ®Google Scholar
• Hansen KE, Bartels CM, Gangnon RE, Jones AN, Gogineni J. An evaluation of high-dose vitamin D for rheumatoid arthritis. J. Clin. Rheumatol. 20(2), 112–114 (2014).
   PubMed Web of Science ®Google Scholar
• Rastmanesh R, Abargouei AS, Shadman Z, Ebrahimi AA, Weber CE. A pilot study of potassium supplementation in the treatment of hypokalemic patients with rheumatoid arthritis: a randomized, double-blinded, placebo-controlled trial. J. Pain 9(8), 722–731 (2008).
   PubMed Web of Science ®Google Scholar
• Nachvak SM, Alipour B, Mahdavi AM et al. Effects of coenzyme Q10 supplementation on matrix metalloproteinases and DAS-28 in patients with rheumatoid arthritis: a randomized, double-blind, placebo-controlled clinical trial. Clin. Rheumatol. 38(12), 3367–3374 (2019).
   PubMed Web of Science ®Google Scholar
• Khojah HM, Ahmed S, Abdel-Rahman MS, Elhakeim EH. Resveratrol as an effective adjuvant therapy in the management of rheumatoid arthritis: a clinical study. Clin. Rheumatol. 37(8), 2035–2042 (2018).
   PubMed Web of Science ®Google Scholar
• Galarraga B, Ho M, Youssef HM et al. Cod liver oil (n-3 fatty acids) as a non-steroidal anti-inflammatory drug sparing agent in rheumatoid arthritis. Rheumatology 47(5), 665–669 (2008).
   PubMed Web of Science ®Google Scholar
• Shishavan NG, Gargari BP, Jafarabadi MA, Kolahi S, Haggifar S, Noroozi S. Vitamin K1 supplementation did not alter inflammatory markers and clinical status in patients with rheumatoid arthritis. Int. J. Vitam. Nutr. Res. 88(5–6), 251–257 (2018).
   PubMed Web of Science ®Google Scholar
• Javadi F, Ahmadzadeh A, Eghtesadi S et al. The effect of quercetin on inflammatory factors and clinical symptoms in women with rheumatoid arthritis: a double-blind, randomized controlled trial. J. Am. Coll. Nutr. 36(1), 9–15 (2017).
   PubMed Web of Science ®Google Scholar
• Zamani B, Farshbaf S, Golkar HR, Bahmani F, Asemi Z. Synbiotic supplementation and the effects on clinical and metabolic responses in patients with rheumatoid arthritis: a randomised, double-blind, placebo-controlled trial. Br. J. Nutr. 117(8), 1095–1102 (2017).
   PubMed Web of Science ®Google Scholar
• Pineda Mde L, Thompson SF, Summers K, de Leon F, Pope J, Reid G. A randomized, double-blinded, placebo-controlled pilot study of probiotics in active rheumatoid arthritis. Med. Sci. Monit. 17(6), CR347–354 (2011).
   PubMed Web of Science ®Google Scholar
• Moosavian SP, Paknahad Z, Habibagahi Z. A randomized, double-blind, placebo-controlled clinical trial, evaluating the garlic supplement effects on some serum biomarkers of oxidative stress, and quality of life in women with rheumatoid arthritis. Int. J. Clin. Pract. 74(7), e13498 (2020).
   PubMed Web of Science ®Google Scholar
• Amalraj A, Varma K, Jacob J et al. A novel highly bioavailable curcumin formulation improves symptoms and diagnostic indicators in rheumatoid arthritis patients: a randomized, double-blind, placebo-controlled, two-dose, three-arm, and parallel-group study. J. Med. Food 20(10), 1022–1030 (2017).
   PubMed Web of Science ®Google Scholar
• Lipsky PE, van der Heijde DM, St Clair EW et al. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-tumor necrosis factor trial in rheumatoid arthritis with concomitant therapy study group. N. Engl. J. Med. 343(22), 1594–1602 (2000).
   PubMed Web of Science ®Google Scholar
• St Clair EW, van der Heijde DM, Smolen JS et al. Active-controlled study of patients receiving infliximab for the treatment of rheumatoid arthritis of Early Onset Study Group. Combination of infliximab and methotrexate therapy for early rheumatoid arthritis: a randomized, controlled trial. Arthritis Rheum. 50(11), 3432–3443 (2004).
   PubMedGoogle Scholar
• Weinblatt ME, Keystone EC, Furst DE et al. Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial. Arthritis Rheum. 48(1), 35–45 (2003).
   PubMed Web of Science ®Google Scholar
• Keystone EC, Kavanaugh AF, Sharp JT et al. Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti-tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: a randomized, placebo-controlled, 52-week trial. Arthritis Rheum. 50(5), 1400–1411 (2004).
   PubMed Web of Science ®Google Scholar
• Cohen S, Hurd E, Cush J et al. Treatment of rheumatoid arthritis with anakinra, a recombinant human interleukin-1 receptor antagonist, in combination with methotrexate: results of a twenty-four-week, multicenter, randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 46(3), 614–624 (2002).
   PubMed Web of Science ®Google Scholar
• Kremer JM, Westhovens R, Leon M et al. Treatment of rheumatoid arthritis by selective inhibition of T-cell activation with fusion protein CTLA4Ig. N. Engl. J. Med. 349(20), 1907–1915 (2003).
   PubMed Web of Science ®Google Scholar
• Edwards JC, Szczepanski L, Szechinski J et al. Efficacy of B-cell-targeted therapy with rituximab in patients with rheumatoid arthritis. N. Engl. J. Med. 350(25), 2572–2581 (2004).
   PubMed Web of Science ®Google Scholar
• Moreland LW, Schiff MH, Baumgartner SW et al. Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial. Ann. Intern. Med. 130(6), 478–486 (1999).
   PubMed Web of Science ®Google Scholar
• Nishimoto N, Yoshizaki K, Miyasaka N et al. Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum. 50(6), 1761–1769 (2004).
   PubMed Web of Science ®Google Scholar
• Trnavský K, Gatterová J, Lindusková M, Pelisková Z. Combination therapy with hydroxychloroquine and methotrexate in rheumatoid arthritis. Z Rheumatol. 52(5), 292–296 (1993).
   PubMed Web of Science ®Google Scholar
• Volker D, Fitzgerald P, Major G, Garg M. Efficacy of fish oil concentrate in the treatment of rheumatoid arthritis. J. Rheum. 27, 2343–2346 (2000).
   PubMed Web of Science ®Google Scholar
• Gharib M, Elbaz W, Darweesh E, Sabri NA, Shaweeki MA. Efficacy and Safety of Metformin Use in Rheumatoid Arthritis: A Randomized Controlled Study. Front Pharmacol 12, 726490 (2021).
   PubMedGoogle Scholar
• Malm K, Bremander A, Arvidsson B, Andersson ML, Bergman S, Larsson I. The influence of lifestyle habits on quality of life in patients with established rheumatoid arthritis—A constant balancing between ideality and reality. Int. J. Qualitat. Studies Health Well-being. 11, 1 (2016).
   Web of Science ®Google Scholar
• Aranow C. Vitamin D and the immune system. J. Investig. Med. 59(6), 881–886 (2011).
   PubMed Web of Science ®Google Scholar
• Liu Z, Ren Z, Zhang J et al. Role of ROS and Nutritional Antioxidants in Human Diseases. Front Physiol. 9, 477 (2018).
   PubMed Web of Science ®Google Scholar
• Rhee SH, Parker JC, Smarr KL et al. Stress management in rheumatoid arthritis: what is the underlying mechanism? Arthritis Care Res. 13(6), 435–442 (2000).
   PubMed Web of Science ®Google Scholar
• Abbasi M, Yazdi Z, Rezaie N. Sleep disturbances in patients with rheumatoid arthritis. Niger J. Med. 22(3), 181–186 (2013).
   PubMedGoogle Scholar
• Ye X, Chen Z, Shen Z, Chen G, Xu X. Yoga for treating rheumatoid arthritis: a systematic review and meta-analysis. Front. Med. 7, 586665 (2020).
   Web of Science ®Google Scholar
• Welch V, Brosseau L, Casimiro L et al. Thermotherapy for treating rheumatoid arthritis. Cochrane Database Syst Rev. 2002(2), CD002826 (2002).
   Google Scholar
• Gioia C, Lucchino B, Tarsitano MG, Iannuccelli C, Di Franco M. Dietary habits and nutrition in rheumatoid arthritis: can diet influence disease development and clinical manifestations? Nutrients 12(5), 1456 (2020).
   PubMed Web of Science ®Google Scholar
• Salgado E, Bes-Rastrollo M, de Irala J, Carmona L, Gomez-Reino JJ. High sodium intake is associated with self-reported rheumatoid arthritis: a cross sectional and case control analysis within the SUN cohort. Medicine 94(37), e0924 (2015).
   PubMed Web of Science ®Google Scholar
• Wu C, Yosef N, Thalhamer T et al. Induction of pathogenic T H 17 cells by inducible salt-sensing kinase SGK1. Nature 496, 513–517 (2013).
   PubMed Web of Science ®Google Scholar
• Serra-Majem L, De la Cruz JN, Ribas L, Tur JA. Olive oil and the Mediterranean diet: beyond the rhetoric. Eur. J. Clin. Nutr. 57, S2–S7 (2003).
   PubMed Web of Science ®Google Scholar
• Bustamante MF, Agustín-Perez M, Cedola F et al. Design of an anti-inflammatory diet (ITIS diet) for patients with rheumatoid arthritis. Contemp. Clin. Trials Commun. 17, 100524 (2020).
   PubMed Web of Science ®Google Scholar
• DeChristopher LR, Uribarri J, Tucker KL. Intake of high-fructose corn syrup sweetened soft drinks, fruit drinks and apple juice is associated with prevalent arthritis in US adults, aged 20–30 years. Nutr. Diabetes 6, e199 (2016).
   PubMed Web of Science ®Google Scholar
• Mikuls TR, Cerhan JR, Criswell LA et al. Coffee, tea, and caffeine consumption and risk of rheumatoid arthritis: Results from the Iowa Women's Health Study. Arthritis Rheum. 46, 83–91 (2002).
   PubMed Web of Science ®Google Scholar
• Heliövaara M, Aho K, Knekt P, Impivaara O, Reunanen A, Aromaa A. Coffee consumption, rheumatoid factor, and the risk of rheumatoid arthritis. Ann. Rheum. Dis. 59, 631–635 (2000).
   PubMed Web of Science ®Google Scholar
• Letarouilly JG, Sanchez P, Nguyen Y et al. Efficacy of spice supplementation in rheumatoid arthritis: a systematic literature review. Nutrients 12(12), 3800 (2020).
   PubMed Web of Science ®Google Scholar
• Luettig J, Rosenthal R, Lee I-FM, Krug SM, Schulzke JD. The ginger component 6-shogaol prevents TNF-α-induced barrier loss via inhibition of PI3K/Akt and NF-κB signaling. Mol. Nutr. Food Res. 60, 2576–2586 (2016).
   PubMed Web of Science ®Google Scholar
• Shimoda H, Shan SJ, Tanaka J et al. Anti-inflammatory properties of red ginger (Zingiber officinale var. Rubra) extract and suppression of nitric oxide production by its constituents. J. Med. Food. 13, 156–162 (2010).
   PubMed Web of Science ®Google Scholar
• Sharma JN, Srivastava KC, Gan EK. Suppressive effects of eugenol and ginger oil on arthritic rats. Pharmacology 49, 314–318 (1994).
   PubMed Web of Science ®Google Scholar
• Athanassiou P, Athanassiou L, Kostoglou-Athanassiou I. Nutritional Pearls: Diet and Rheumatoid Arthritis. Mediterr. J. Rheumatol. 31, 319–324 (2020).
   PubMedGoogle Scholar
• Gunes-Bayir A, Mendes B, Dadak A. The integral role of diets including natural products to manage rheumatoid arthritis: a narrative review. Curr. Iss. Mol. Biol. 45(7), 5373–5388 (2023).
   PubMed Web of Science ®Google Scholar
• Elmenshawy HO, Farouk HM, Sabri NA, Ahmed MA. The impact of pharmaceutical care services on patients with active rheumatoid arthritis: a randomized controlled study. Arch. Pharmaceut. Sci. Ain Shams Univ. 6(1), 141–155 (2022).
   Google Scholar
• Kurkó J, Besenyei T, Laki J, Glant TT, Mikecz K, Szekanecz Z. Genetics of rheumatoid arthritis - a comprehensive review. Clin. Rev. Allergy Immunol. 45(2), 170–179 (2013).
   PubMed Web of Science ®Google Scholar
• Pawlik A, Wrzesniewska J, Fiedorowicz-Fabrycy I, Gawronska-Szklarz B. The MDR1 3435 polymorphism in patients with rheumatoid arthritis. Int. J. Clin. Pharmacol. Ther. 42(9), 496–503 (2004).
   PubMed Web of Science ®Google Scholar
• Davila L, Ranganathan P. Pharmacogenetics: implications for therapy in rheumatic diseases. Nat. Rev. Rheumatol. 7(9), 537–550 (2011).
   PubMed Web of Science ®Google Scholar
• Tolusso B, Pietrapertosa D, Morelli A et al. IL-1B and IL-1RN gene polymorphisms in rheumatoid arthritis: relationship with protein plasma levels and response to therapy. Pharmacogenomics 7(5), 683–695 (2006).
   PubMed Web of Science ®Google Scholar
• Saunders SA, Capell HA, Stirling A et al. Triple therapy in early active rheumatoid arthritis: a randomized, single-blind, controlled trial comparing step-up and parallel treatment strategies. Arthritis Rheum. 58(5), 1310–1317 (2008).
   PubMedGoogle Scholar
• Allaart CF, Breedveld FC, Dijkmans BA. Treatment of recent-onset rheumatoid arthritis: lessons from the BeSt study. J. Rheumatol. Suppl. 80, 25–33 (2007).
   PubMedGoogle Scholar
• Krüger K, Edelmann E. Therapieabbau bei stabil eingestellter rheumatoider Arthritis. Stand des Wissens [Treatment reduction in well-controlled rheumatoid arthritis. State of knowledge]. Z Rheumatol. 74(5), 414–420 (2015).
   PubMedGoogle Scholar